Dennis C. Shrieve

Papers

Total Citations

H-Index

About

Dennis C. Shrieve is a leading figure in radiation oncology, with a career dedicated to advancing the precision and safety of stereotactic radiosurgery and radiotherapy. His research focuses on the technical optimization of dose delivery for complex anatomical sites, particularly the spine and brain. A key contribution is his work on apparatus-dependent dosimetric differences in spine stereotactic body radiotherapy (SBRT), where his multi-institutional study (cited 25 times) critically compared treatment planning systems, including the CyberKnife and intensity-modulated radiotherapy, to identify how equipment choice affects dose distribution and target coverage. This work has directly informed clinical protocols, helping to reduce the risk of radiation-induced myelopathy. Beyond this, Shrieve has made foundational contributions to the management of brain metastases and primary brain tumors, including seminal studies on the role of radiosurgery in combination with whole-brain radiotherapy. His research, which has garnered thousands of citations, has shaped national treatment guidelines and remains essential reading for clinicians and physicists seeking to balance tumor control with normal tissue sparing in high-precision radiotherapy.